Company Filing History:
Years Active: 2025
Title: Zhicong Shi: Innovator in NLRP3 Inflammasome Inhibitors
Introduction
Zhicong Shi is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds that target the NLRP3 inflammasome.
Latest Patents
Zhicong Shi holds a patent for NLRP3 inflammasome inhibitors. The patent describes novel pyridazin-3-yl phenol compounds that inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. This invention also details the processes for preparing these compounds, as well as the pharmaceutical compositions and medicaments that contain them. The compounds are intended for use in treating diseases and disorders mediated by NLRP3.
Career Highlights
Zhicong Shi is currently associated with Novartis AG, a leading global healthcare company. His work focuses on innovative solutions in drug development, particularly in the area of inflammatory diseases.
Collaborations
Zhicong has collaborated with notable colleagues, including Xiaobin Ge and Henri Mattes, to advance research and development in his field.
Conclusion
Zhicong Shi's work on NLRP3 inflammasome inhibitors represents a significant advancement in the treatment of inflammatory diseases. His contributions to pharmaceutical innovation continue to impact the healthcare industry positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.